Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,553 across all filing types
Latest filing 2019-09-11 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Update - Dividend/Distribution - CSL 4 pages 35.0KB
Regulatory Filings
2019-09-11 English
CSL Annual Report 2018/19 144 pages 6.8MB
Regulatory Filings
2019-09-05 English
CSL Notice of 2019 Annual General Meeting 20 pages 1.1MB
Regulatory Filings
2019-09-05 English
Notice of 2020 Dividend and AGM Dates 1 page 100.9K
Regulatory Filings
2019-09-05 English
Appendix 4G 12 pages 393.3KB
Regulatory Filings
2019-09-05 English
CSL Shareholders Pack 2019 4 pages 249.2KB
Regulatory Filings
2019-09-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.